Tom Van Loy

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 23

Top Venues

Cancer immunology, immunotherapy : CII

Biosensors

Molecules (Basel, Switzerland)

Pharmaceutics

Zoological Institute, KU Leuven (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Zoological Institute, KU Leuven Oct 01 2001 - May 30 2006

Belgium

PHD :: Biology

Publications

Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Isaline Renard, Thomas D'huys, Benjamin P Burke, Trisha Ajoleza, Amy N Cain, Neil L Funwie, Abid Khan, Danny L Maples, Randall D Maples, Dallas L Matz, Graeme McRobbie, Robert Ullom, Timothy John Prior, Douglas P Linder, Tom Van Loy, Timothy J Hubin, Dominique Schols, Stephen J Archibald
Rigid Macrocycle Metal Complexes as CXCR4 Chemokine Receptor Antagonists: Influence of Ring Size. Pharmaceutics 16 (8) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Libao Liu, Laurie Rangan, Nathan Vanalken, Qianqian Kong, Susan M Schlenner, Steven De Jonghe, Dominique Schols, Tom Van Loy
Development of a cellular model to study CCR8 signaling in tumor-infiltrating regulatory T cells. Cancer immunology, immunotherapy : CII 73 (1) (2024)
Nathan Vanalken, Katrijn Boon, Martyna Szpakowska, Andy Chevigné, Dominique Schols, Tom Van Loy
Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context. Biosensors 14 (3) (2024)
Nathan Vanalken, Katrijn Boon, Martyna Szpakowska, Andy Chevigné, Dominique Schols, Tom Van Loy
Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context. Biosensors 14 (3) (2024)
Isaline Renard, Thomas D'huys, Benjamin P Burke, Trisha Ajoleza, Amy N Cain, Neil L Funwie, Abid Khan, Danny L Maples, Randall D Maples, Dallas L Matz, Graeme McRobbie, Robert Ullom, Timothy John Prior, Douglas P Linder, Tom Van Loy, Timothy J Hubin, Dominique Schols, Stephen J Archibald
Rigid Macrocycle Metal Complexes as CXCR4 Chemokine Receptor Antagonists: Influence of Ring Size. Pharmaceutics 16 (8) (2024)
Nathan Vanalken, Katrijn Boon, Martyna Szpakowska, Andy Chevigné, Dominique Schols, Tom Van Loy
Systematic Assessment of Human CCR7 Signalling Using NanoBRET Biosensors Points towards the Importance of the Cellular Context. Biosensors 14 (3) (2024)
Max Van Hoof, Sandra Claes, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe
Exploration of Pyrido[3,4- d ]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2. Molecules (Basel, Switzerland) 28 (5) (2023)
Max Van Hoof, Sandra Claes, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe
Exploration of Pyrido[3,4- d ]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2. Molecules (Basel, Switzerland) 28 (5) (2023)
Katrijn Boon, Nathan Vanalken, Eef Meyen, Dominique Schols, Tom Van Loy
REGA-SIGN: Development of a Novel Set of NanoBRET-Based G Protein Biosensors. Biosensors 13 (8) (2023)
Max Van Hoof, Sandra Claes, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe
Exploration of Pyrido[3,4- d ]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2. Molecules (Basel, Switzerland) 28 (5) (2023)
Max Van Hoof, Sandra Claes, Katrijn Boon, Tom Van Loy, Dominique Schols, Wim Dehaen, Steven De Jonghe
Exploration of Pyrido[3,4- d ]pyrimidines as Antagonists of the Human Chemokine Receptor CXCR2. Molecules (Basel, Switzerland) 28 (5) (2023)
Nathan Vanalken, Katrijn Boon, Jordi Doijen, Dominique Schols, Tom Van Loy
Cellular Electrical Impedance as a Method to Decipher CCR7 Signalling and Biased Agonism. International journal of molecular sciences 23 (16) (2022)
Tom Van Loy, Steven De Jonghe, Karolien Castermans, Wouter Dheedene, Reinout Stoop, Lars Verschuren, Matthias Versele, Patrick Chaltin, Aernout Luttun, Dominique Schols
Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model. Cellular and molecular life sciences : CMLS 79 (6) (2022)
Mastaneh Safarnejad Shad, Sandra Claes, Eline Goffin, Tom Van Loy, Dominique Schols, Steven De Jonghe, Wim Dehaen
Synthesis and Anti-HIV Activity of a Novel Series of Isoquinoline-Based CXCR4 Antagonists. Molecules (Basel, Switzerland) 26 (20) (2021)
Kaat Luyten, Tom Van Loy, Christopher J Cawthorne, Christophe M Deroose, Dominique Schols, Guy Bormans, Frederik Cleeren
D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy. Pharmaceutics 13 (10) (2021)
Arnaud Boonen, Abhimanyu K Singh, Anneleen Van Hout, Kalyan Das, Tom Van Loy, Sam Noppen, Dominique Schols
Development of a Novel SPR Assay to Study CXCR4-Ligand Interactions. Biosensors 10 (10) (2020)
Anneleen Van Hout, Thomas D'huys, Merel Oeyen, Dominique Schols, Tom Van Loy
Comparison of cell-based assays for the identification and evaluation of competitive CXCR4 inhibitors. PloS one 12 (4) (2017)

Tom Van Loy.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tom Van Loy